Eculizumab, a groundbreaking monoclonal antibody, has revolutionized the treatment of rare and life-threatening diseases by targeting the complement system. This powerful drug works by inhibiting
Tafamidis is a medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and serious condition where a misfolded protein called transthyretin (TTR) accumulates in